全文获取类型
收费全文 | 1207202篇 |
免费 | 84691篇 |
国内免费 | 4381篇 |
专业分类
耳鼻咽喉 | 17070篇 |
儿科学 | 31073篇 |
妇产科学 | 31097篇 |
基础医学 | 172728篇 |
口腔科学 | 36639篇 |
临床医学 | 104472篇 |
内科学 | 237462篇 |
皮肤病学 | 25547篇 |
神经病学 | 92376篇 |
特种医学 | 46104篇 |
外国民族医学 | 163篇 |
外科学 | 192889篇 |
综合类 | 27734篇 |
现状与发展 | 5篇 |
一般理论 | 291篇 |
预防医学 | 75725篇 |
眼科学 | 29243篇 |
药学 | 95184篇 |
10篇 | |
中国医学 | 4456篇 |
肿瘤学 | 76006篇 |
出版年
2019年 | 8629篇 |
2018年 | 12999篇 |
2017年 | 10166篇 |
2016年 | 10974篇 |
2015年 | 12542篇 |
2014年 | 17157篇 |
2013年 | 24211篇 |
2012年 | 33225篇 |
2011年 | 34480篇 |
2010年 | 20434篇 |
2009年 | 19432篇 |
2008年 | 32669篇 |
2007年 | 34654篇 |
2006年 | 35091篇 |
2005年 | 33341篇 |
2004年 | 31918篇 |
2003年 | 30490篇 |
2002年 | 29767篇 |
2001年 | 72459篇 |
2000年 | 74317篇 |
1999年 | 61731篇 |
1998年 | 14618篇 |
1997年 | 12639篇 |
1996年 | 12284篇 |
1995年 | 11472篇 |
1994年 | 10496篇 |
1993年 | 9660篇 |
1992年 | 45523篇 |
1991年 | 43132篇 |
1990年 | 41437篇 |
1989年 | 40545篇 |
1988年 | 36762篇 |
1987年 | 35800篇 |
1986年 | 33340篇 |
1985年 | 31615篇 |
1984年 | 22325篇 |
1983年 | 18782篇 |
1982年 | 9720篇 |
1979年 | 19509篇 |
1978年 | 12998篇 |
1977年 | 11187篇 |
1976年 | 9545篇 |
1975年 | 10533篇 |
1974年 | 12716篇 |
1973年 | 11964篇 |
1972年 | 11402篇 |
1971年 | 10894篇 |
1970年 | 10256篇 |
1969年 | 9705篇 |
1968年 | 8853篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Amy Y. Zhang Christopher Burant Alex Z. Fu Gerald Strauss Donald R. Bodner Lee Ponsky 《Journal of psychosocial oncology》2020,38(2):210-227
AbstractPurpose: We examined underlying psychosocial processes of a behavioral treatment for urinary incontinence (UI) of prostate cancer survivors.Design: Secondary analysis of data collected from a clinical trial.Sample: Two hundred forty-four prostate cancer survivors who participated in a clinical trial of behavioral intervention to UI as intervention or control subjects.Methods: The participants had a 3-month behavioral intervention or usual care and were followed up for an additional 3?months. They were assessed at baseline, 3, and 6?months. Latent growth curve models were performed to examine trajectories of each study variable and relationships among the variables.Findings: Increasing self-efficacy and social support were significantly and independently associated with more reduction of urinary leakage frequency over time.Implications for psychosocial oncology: Providing problem-solving skills and social support, including peer support, are essential for empowering patients to reduce UI. 相似文献
102.
103.
Prevalence of Potentially Inappropriate Prescribing Among Hong Kong Older Adults: A Comparison of the Beers 2003, Beers 2012, and Screening Tool of Older Person's Prescriptions and Screening Tool to Alert doctors to Right Treatment Criteria 下载免费PDF全文
104.
105.
D. Sforza G. Iaria L. Petagna A. Parente A. Anselmo F. Sergi S. Marzio F. Corrado S. Telli T.M. Manzia G. Tisone 《Transplantation proceedings》2019,51(1):140-142
Background
One daily dose of tacrolimus (QDT) improves adherence in kidney transplant (KT) recipients. A switch from twice-daily tacrolimus (BDT) to QDT showed similar efficacy and safety.Methods
The aim of our study was to demonstrate the long-term efficacy and safety of switching from BDT to QDT in KT recipients. Preliminary results have already been published. Forty-one patients (34 men and 7 women), mean age at KT of 43.9 ± 12.7 years, underwent a 1:1 dose switch from BDT to QDT; the mean time from KT to switch was 36.6 ± 16.1 months. In our study population, 4 patients received a living donor KT and 2 received a second allograft.Results
The mean follow-up was 86.8 ± 13 months from the switch and 126.2 ± 22.3 months from KT. Graft and patient survival rates were 90.2% and 95.1%, respectively. All patients maintained stable renal function during follow-up. During the first 3 months after the switch we observed a significant decrease in tacrolimus blood level (P = .0001). No significant differences were observed regarding tacrolimus dose before and after QDT introduction (P = not significant [NS]). Fourteen patients who stopped steroids under BDT treatment and 16 patients who stopped steroids after the switch are currently steroid-free.Conclusion
Our study showed safety and efficacy in switching from BDT to QDT. After early (<1 year) dose adjustment, tacrolimus blood levels remained stable throughout follow-up. Moreover, QDT represented a valid alternative for patients showing steroid side effects. 相似文献106.
Nicotine,the principal neuroactive component of tobacco,acts on the reward systems of smokers,inducing addiction.Experimental evidence indicates that nicotine-induced addiction alters the activity of dopaminergic neurons within reward-processing brain centers.The effect of developmental nicotine exposure on neuroplasticity of identified reward neurocircuitry in the adult is finally emerging and begins to be understood at the molecular,cellular,and behavioral level(Romoli et al.,2019). 相似文献
107.
Laysa Toschi Martins Henrique Ravanhol Frigeri Caio Cesar Silva de Castro Marcelo Távora Mira 《Experimental dermatology》2020,29(6):535-538
The aetiology of vitiligo has not been fully elucidated, and several hypotheses have been investigated; among them, the most explored assumes an autoimmune basis for the disease. Supporting this hypothesis is the frequent co-occurrence of autoimmune diseases with vitiligo. In addition, various genetic loci associated with vitiligo harbour key immune response genes. Our general hypothesis is that autoimmunity-associated genes participate in the control of vitiligo susceptibility. To investigate this hypothesis, we tested for association between vitiligo and genes CYP27B1, REL, TNFAIP3 and IL2/IL21, all previously related to autoimmune diseases associated with vitiligo. The study was performed using two independent population samples: a family-based discovery set (211 trios) and a replication set (131 cases/119 controls). Statistically significant association with vitiligo was detected between markers of the REL and IL2 gene in the family-based sample. Both association signals were concentrated among patients displaying autoimmune comorbidity and non-segmental vitiligo. Evidence for validation was detected for IL2 marker. Our findings suggest REL and IL2 as new vitiligo susceptibility genes and reinforce the hypothesis of a shared genetic mechanism controlling vitiligo and other autoimmune diseases. 相似文献
108.
109.
110.